Indeed, restoring CX3CL1 expression in the MBH protects from HFD-induced obesity (DIO) [20], but the mechanisms linking CX3CL1 action—and more generally, microglial activation—to metabolic alterations remain unclear. The gene discussed is CX3CL1; the disease is obesity due to melanocortin 4 receptor deficiency.